Contact Us

MEETING NEWS

Appian Announces 2024 APJ Partner Award Winners

Nov 28, 2024

Recognising WNS-Vuram,Deloitte,Cognizant,KPMG,Accenture,and Via Appia for delivering process excellence

Global Times: US firms showcase strong collaboration with Chinese supply chains at 2nd CISCE

Nov 28, 2024

BEIJING,Nov. 28,2024-- At the ongoing 2nd China International Supply Chain Expo (CISCE) in Beijing,US companies have a prominent presence,as leading companies such as Apple and Tesla showcased their s

SHEIN is launching the ULTIMATE Giftorium experience just in time for the Festive Season

Nov 28, 2024

MELBOURNE,Australia,Nov. 28,2024-- Global fashion giant SHEIN will bring the ultimate Giftorium experience to life,right in time for the festive season.

Celebrate the Season of Gratitude with baleaf: Stay Warm and Stylish This Winter with Our Best-Selling Fleece-Lined Yoga Pants

Nov 28, 2024

NEW YORK,Nov. 27,2024--As winter settles in,it\'s the perfect time to reflect on the warmth and comfort that help us through the colder months. This season of gratitude,baleaf proudly celebrates a dec

The trading volume of green electricity in Turfan, Xinjiang exceeded 50 million kilowatt-hours

Nov 28, 2024

TURFAN,China,Nov. 28,2024-- As of November 24,the trading power of green power in Turfan,Xinjiang this year has reached 50.3205 million kilowatt-hours,successfully breaking through the 50 million kilo

HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals Announce Successful Completion of a First-in-Human Study for Potential Disease-Modifying Therapy for Parkinson's Disease

Nov 26, 2024

HL192 (ATH-399A) was well tolerated with no major safety issues in any of the 76 participants. No serious treatment related adverse events were reported and such findings were proportional between pl

1 ... 188 189 190 191 192 193 194 ... 332